Diabetes Information

  • Diabetes Educators Slider

    We believe: The greatest solutions arise from collaboration.

    Evidence + Judgment = Best Care

    Start Here

Latest Updates

Update: New Endocrinology & Metabolism Program website

The Endocrinology & Metabolism Program has had a public website available for a number of years, located at https://www.ucalgary.ca/cdm/ The platform is being decommissioned, so we have moved the content to a new platform with new URL: https://cumming.ucalgary.ca/resources/endocrinology-metabolism  You can also access it by typing endometab.ca in the browser address window, then <Enter>. You will be redirected to the new site.

Diabetes Educators are encouraged to continue to use the current one that you're on. 

Update: Glargine and Biosimilars Initiative

Some of your patients may be switched from Lantus to Basalgar in the upcoming year. The Alberta Biosimilars initiative will impact those on Alberta Goverment sponsored drug programs (not Blue Cross group or individual plans). Patients on glargine (Lantus) will be required to switch to glargine (Basaglar) for cost savings by June 30, 2020. Read more here

Update: Health Canada News re: Metformin

Health Canada released a safety alert regarding Metformin and possible contamination with N-nitrosodimethylamine (NDMA) - a suspected carcinogen- outside of Canada. There is no cause for concern in Canada at this time. Patients may ask educators about this if they hear of product recalls in other countries. For more details on this safety alert please visit our Diabetes Update

Diabetes Update Sign-Up

Stay up-to-date with diabetes education and management. Receive updates on new medications, products, continuing education for healthcare professionals and more by signing up for our periodic emails.

To view past updates, please visit our archives.